Hudson Bay Capital Management »

Gracell Biotechnologies shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Gracell Biotechnologies shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Gracell Biotechnologies

Tip: Access up to 7 years of quarterly data

All positions including Gracell Biotechnologies held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gracell Biotechnologies by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.7M 267k 10.04
2023-09-30 $1.1M 2.0M 0.56

More positions owned by Hudson Bay Capital Management

Amazon Call Option (AMZN)
Microsoft Corporation Put Option (MSFT)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Advanced Micro Devices Put Option (AMD)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Meta Platforms Cl A Put Option (META)
Berkshire Hathaway Inc Del Cl B New Put Option (BRK.B)
Alphabet Cap Stk Cl C Put Option (GOOG)
Apple Put Option (AAPL)
Royal Caribbean Group Note 6.000% 8/1 (Principal)
NVIDIA Corporation Put Option (NVDA)
salesforce Put Option (CRM)
Select Sector Spdr Tr Financial (XLF)
Adobe Systems Incorporated Put Option (ADBE)
Boeing Company Put Option (BA)

View all positions for Hudson Bay Capital Management

Top funds holding Gracell Biotechnologies

OrbiMed Advisors
Tang Capital Management
Baker Bros. Advisors
Pentwater Capital Management
TIG Advisors
Alpine Associates Management
Octagon Capital Advisors
Bank of America Corporation
LMR Partners
Sphera Funds Management
MMCAP International Inc. SPC
Hudson Bay Capital Management
Marshall Wace
Millennium Management
CNH Partners

View all funds holding Gracell Biotechnologies